Sell Your Healthcare or Life Sciences Business

A scientist wearing a lab coat and gloves uses a pipette to transfer liquid into a test tube at a laboratory workbench filled with equipment, containers, and samples—precision that’s essential when you’re ready to sell your business.

Sector Expertise That Drives Value

We provide straightforward, honest advice tailored to healthcare and life sciences businesses, ensuring your regulatory strength, clinical credibility, intellectual property and growth potential are clearly articulated. By addressing compliance, commercial and operational considerations early, we position your business to resonate with strategic buyers and investors – maximising value and increasing deal certainty.

Reach out to us

With practical support, clear strategy and sector-focused M&A insight, we’ll help you move forward with confidence in a transaction that reflects the true strength of your business.

How we support our clients

Straightforward Advice

We provide clear, commercially focused advice tailored to healthcare and life sciences businesses. Our guidance reflects the sector’s regulatory complexity, clinical validation requirements and innovation-driven growth models.

Preparation That Strengthens Value

We assess your business through a buyer’s lens – reviewing regulatory compliance, clinical data, intellectual property protection, reimbursement pathways, revenue visibility and scalability. Addressing these factors early strengthens buyer confidence and valuation.

Complete Confidentiality

Discretion is critical in regulated markets. We implement secure processes and controlled communications to protect sensitive data, intellectual property, clinical information and key stakeholder relationships throughout the transaction.

Expert Team

Our team understands the nuances of healthcare and life sciences transactions, from early-stage innovation businesses to established commercial operators. We combine sector insight with deal expertise to guide you at every stage.

Proactive Approach

We conduct detailed market mapping and confidentially engage strategic acquirers, global healthcare groups and specialist investors. By managing competitive tension and deal momentum, we optimise value and transaction certainty.

International Buyer Reach

Healthcare and life sciences is a global market. Leveraging international databases and our expanding cross-border network, we identify the right strategic and financial buyers – including overseas groups seeking innovation and UK market access.

A lab worker in a white coat sits at a cluttered laboratory desk. Overlaid text reads: MedTech & IVD Market. Explore this M&A report on the MedTech & IVD Market.

M&A activity in the UK MedTech industry – including IVD and distribution – remains strong, driven by strategic acquirers and private equity seeking innovative technologies, expanded geographic reach and portfolio optimisation.

Download our MedTech M&A Guide to understand the latest trends, valuations and how to position your business for a successful sale.

Download

Our Success Stories

Our experienced team ensures every transaction is handled with integrity, expertise, and a commitment to great results. Explore some of our recent successes in your sector below.

Alpha Laboratories acquired by Diploma PLC

“This transaction would have been almost impossible without the support of Entrepreneurs Hub. With this sale we are confident we are leaving the company in good hands, and the trusted brand of Alpha Laboratories will continue to thrive for generations to come.”

Nathan Giles

Alpha Laboratories

FAQs – Healthcare & Life Sciences Sector

How do I sell my healthcare business in the UK?

To sell your healthcare business in the UK, you need structured preparation, valuation and confidential engagement with qualified buyers. Buyers assess regulatory compliance, revenue visibility, service contracts, CQC history and operational resilience. Clear documentation and robust financial reporting improve valuation and deal certainty.

How much is my life sciences or MedTech company worth?

A life sciences or MedTech company is typically valued using revenue or EBITDA multiples, depending on profitability and growth stage. Valuation depends on intellectual property protection, regulatory approvals, commercial traction and scalability. Companies with defensible technology and strong growth potential often achieve premium multiples.

Is now a good time to sell my healthcare or MedTech business?

M&A activity in the UK healthcare and life sciences sector remains active, driven by consolidation and private equity investment. Buyers are seeking specialist capability, innovative technologies and scalable platforms. Strong, compliant businesses continue to attract competitive interest.

What do buyers look for when acquiring a healthcare company?

Buyers look for regulatory compliance, predictable revenue, diversified income streams and scalable operations. They also assess workforce stability, quality standards and contractual security. Clear competitive positioning increases buyer confidence and valuation potential.

How can I increase the value of my healthcare or life sciences business before selling?

To increase value, focus on strengthening compliance documentation, protecting intellectual property and improving revenue visibility. Demonstrating sustainable margins, strong governance and growth potential can significantly enhance buyer confidence and valuation.